Short answer
LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on September 29, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement). Alcon manufacturing agreement extended from December 31, 2031 to December 31, 2034.
LIFECORE BIOMEDICAL, INC. DE 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- Alcon manufacturing agreement extended from December 31, 2031 to December 31, 2034
- Automatic 24-month renewals after 2034, subject to termination notice
- Alcon minimum purchase obligations established through 2034, supporting longer-term revenue visibility
- Lifecore restricted from new agreements directly competing with certain Alcon products beginning November 1, 2026
- Existing competitive contracts may continue, renew, or be replaced on substantially similar or more favorable terms
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LIFECORE BIOMEDICAL, INC. DE 8-K filings
Get the next LFCR 8-K as it lands
Follow LFCR for push alerts, or ask the research agent what this filing means.